Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Neonatal Respiratory Health Research, and IL-33, ST2, and ILC Pathways.
Nasal gene expression shows a distinct signature in type 2–high asthma but not in type 2–low disease
Current Smoker: A Clinical Chronic Obstructive Pulmonary Disease Phenotype Affecting Disease Progression and Response to Therapy
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study
Improved Annotation of Asthma Gene Variants with Cell Type Deconvolution of Nasal and Lung Expression Quantitative Trait Loci
Detecting Small Airways Dysfunction in Asthma: Rationale, Findings, and Future of ATLANTIS
Prevalence and clinical characteristics of persistent airflow limitation in a cohort of adults with asthma and/or chronic obstructive pulmonary disease
Cluster Analysis to Identify Distinct Asthma Phenotypes in the <scp>ATLANTIS</scp> Cohort
Small Airways Dysfunction Independently Predicts Exacerbation Risk in Patients with Well-Controlled Asthma: An Analysis within the ATLANTIS Study
Cluster analysis to identify distinct clinical asthma phenotypes in the ATLANTIS cohort
Reply to Correspondence: The Bronchodilator and Anti‐Inflammatory Effect of Long‐Acting Muscarinic Antagonists in Asthma: An <scp>EAACI</scp> Position Paper
Distal Lung Inflammation Correlates With Systemic Inflammation and Small Airway Disease: Data From the ATLANTIS Study
Clinical Phenotyping of Asthma in the ATLANTIS Cohort: The Role of Sputum Eosinophils in Patients With Low Blood Eosinophils
Investigation of the Relationship Between Blood Eosinophil Count and Small Airway Dysfunction Identifies Potential Asthma Endotypes in the ATLANTIS Study
A Computational Approach for Detection of Novel Circular RNAs (circRNA) from the ATLANTIS Study
Asthma Patients With Isolated Sputum Eosinophilia Exhibit Distinct Nasal Gene Expression Profile
SHAP-Prioritised Machine Learning for Diagnostic-Grade Prediction of Lung Function
Diagnostic grade SHAP-prioritised machine learning for spirometry from high-dimensional qCT
A novel dual-branch CNN architecture for explainable feature agnostic predictions in asthma
Oscillometry bronchodilator response identifies distinct pathophysiological phenotypes in the ATLANTIS cohort
Distinct epigenetic nasal signature in T2-low asthma
Combined physiological and inflammatory biomarker assessment for risk stratification in moderate-to-severe asthma
Burden, characteristics and outcomes of COPD patients experiencing moderate or severe exacerbations on triple therapy (ANTLIA NOVELTY)
Plasma proteomic profiles for eosinophilic inflammation in NOVELTY
Lung-function trajectories: relevance and implementation in clinical practice
Exploring the genetics of airflow limitation in lung function across the lifespan – a polygenic risk score study
The Bronchodilator and Anti‐Inflammatory Effect of Long‐Acting Muscarinic Antagonists in Asthma: An <scp>EAACI</scp> Position Paper
Altered Extracellular Vesicle-Derived Protein and microRNA Signatures in Bronchoalveolar Lavage Fluid from Patients with Chronic Obstructive Pulmonary Disease
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study
Nasal epithelial gene expression identifies relevant asthma endotypes in the ATLANTIS study
Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomics